Estrogen deficiency accelerates progression of glomerulosclerosis in susceptible mice

American Journal of Pathology

Volumn 162, Issue 5, 2003, Pages 1441-1448

  Elliot, Sharon J ^b   Karl, Michael ^a   Berho, Mariana ^b   Potier, Mylene ^b   Zheng, Feng ^b   Leclercq, Baudouin ^b   Striker, Gary E ^b   Striker, Liliane J ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; ESTROGEN; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE EXACERBATION; ELECTRON MICROSCOPY; ESTROGEN DEFICIENCY; EXTRACELLULAR MATRIX; FEMALE; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; IMMUNOFLUORESCENCE MICROSCOPY; MOUSE; NONHUMAN; OVARIECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UREA BLOOD LEVEL; ZYMOGRAPHY;

EID: 0242585418     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64277-0     Document Type: Article

References (24)

1. U. S. Renal Data System: USRDS 2000 Annual Data Report. Bethesda MD, The National Institutes of Health, NIDDK, 2000
2. Butkus DE: Familial clustering of end-stage renal disease in Mississippi. J Miss State Med Assoc 2002, 43:71-77
3. Lenz O, Zheng F, Vilar J, Doublier S, Lupia E, Schwedler S, Striker LJ, Striker GE: The inheritance of glomerulosclerosis in mice is controlled by multiple quantitative trait loci. Nephrol Dial Transplant 1998, 13: 3074-3078
4. Webb P, Lopez GN, Greene GL, Baxter JD, Kushner PJ: The limits of the cellular capacity to mediate an estrogen response. Mol Endocrinol 1992, 6:157-167
5. Potier M, Elliot SJ, Tack I, Lenz O, Striker GE, Striker LJ, Karl M: Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9. J Am Soc Nephrol 2001, 12:241-251
6. Potier M, Karl M, Zheng F, Elliot SJ, Striker GE, Striker LJ: Estrogenrelated abnormalities in glomerulosclerosis-prone mice: reduced mesangial cell estrogen receptor expression and prosclerotic response to estrogens Am J Pathol 2002, 160:1877-1885
7. Lei J, Silbiger S, Ziyadeh FN, Neugarten J: Serum-stimulated alpha 1 type IV collagen gene transcription is mediated by TGF-beta and inhibited by estradiol Am J Physiol 1998, 274:F252-F258
8. Neugarten J, Medve I, Lei J, Silbiger SR: Estradiol suppresses mesangial cell type I collagen synthesis via activation of the MAP kinase cascade. Am J Physiol 1999, 277:F875-F881
9. Silbiger S, Lei J, Neugarten J: Estradiol suppresses type I collagen synthesis in mesangial cells via activation of activator protein-1. Kidney Int 1999, 55:1268-1276
10. He C, Zalups RK, Henderson DA, Striker GE, Striker LJ: Molecular analysis of spontaneous glomerulosclerosis in Os/+ mice, a model with reduced nephron mass. Am J Physiol 1995, 269:F266-F273
11. He CJ, Esposito C, Phillips C, Zalups RK, Henderson DA, Striker GE, Striker LJ: Dissociation of glomerular hypertrophy, cell proliferation and glomerulosclerosis in mouse strains heterozygous for a mutation (Os) which induces a 50% reduction in nephron number. J Clin Invest 1996, 97:1-8
12. Esposito C, He CJ, Striker GE, Zalups RK, Striker LJ: Nature and severity of the glomerular response to nephron reduction is straindependent in mice. Am J Pathol 1999, 154:891-897
13. Zheng F, Striker G, Esposito C, Lupia E, Striker L: Strain differences rather than hyperglycemia determine the severity of glomerulosclerosis in mice. Kidney Int 1998, 54:1999-2007
14. Herrington DM, Reboussin DM, Brosnihan KB, Sharp PC, Shumaker SA, Snyder TE, Furberg CD, Kowalchuk GJ, Stuckey TD, Rogers WJ, Givens DH, Waters D: Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med 2000, 343:522-529
15. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA 1998, 280:605-613
16. Pesce CM, Striker LJ, Peten E, Elliot SJ, Striker GE: Glomerulosclerosis at both early and late stages is associated with increased cell turnover in mice transgenic for growth hormone. Lab Invest 1991, 65:601-605
17. Peten EP, Garcia-Perez A, Terada Y, Woodrow D, Martin BM, Striker GE, Striker LJ: Age-related changes in alpha 1- and alpha 2-chain type IV collagen mRNAs in adult mouse glomeruli: competitive PCR. Am J Physiol 1992, 263:F951-F957
18. vom Saal FS, Finch CE, Nelson JF: Natural history and mechanisms of reproductive aging in humans, laboratory rodents, and other selected vertebrates. The Physiology of Reproduction Edited by E Knobil, JD Neill. New York, Raven Press, 1994, pp 1213-1314
19. Zhu Y, Bian Z, Lu P, Karas RH, Bao L, Cox D, Hodgin J, Shaul PW, Thoren P, Smithies O, Gustafsson JA, Mendelsohn ME: Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta Science 2002, 295:505-508
20. Carson DD, Farrar JD, Laidlaw J, Wright DA: Selective activation of the N-glycosylation apparatus in uteri by estrogen J Biol Chem 1990, 265:2947-2955
21. Pawluczyk IZ, Harris KP: Macrophages promote prosclerotic responses in cultured rat mesangial cells: a mechanism for the initiation of glomerulosclerosis J Am Soc Nephrol 1997, 8:1525-1536
22. Frazier-Jessen MR, Mott FJ, Witte PL, Kovacs EJ: Estrogen suppression of connective tissue deposition in a murine model of peritoneal adhesion formation. J Immunol 1996, 156:3036-3042
23. Seli E, Pehlivan T, Selam B, Garcia-Velasco JA, Arici A: Estradiol down-regulates MCP-1 expression in human coronary artery endothelial cells. Fertil Steril 2002, 77:542-547
24. Hodges YK, Richer JK, Horwitz KB, Horwitz LD: Variant estrogen and progesterone receptor messages in human vascular smooth muscle. Circulation 1999, 99:2688-2693